TriSalus Life Sciences, Inc. TLSI Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 84.6%-1.5pp | 86.1%+0.1pp | 85.9%— | —— | |
| Operating margin | -59.7%+63.2pp | -122.9%+171pp | -294%— | —— | |
| Net margin | -86.9%+15.2pp | -102.1%+219pp | -320.7%— | —— | |
| Efficiency | |||||
| Asset turnover | 1.5×+0.3× | 1.2×+0.4× | 0.8×— | —— | |
| Liquidity | |||||
| Current ratio | 2.8×+0.8× | 2×+0.6× | 1.4×+0.9× | 0.5×+0.2× | |
| Per Share | |||||
| Book value per share | -$0.89+12.6% | -$1.02+64.5% | -$2.88+99.5% | -$572.12-10,936% | |
| Valuation | |||||
| Market capitalization | $279.45M+49.6% | $152.77M+92.4% | $79.39M-73.3% | $296.97M-3.8% | |
| Price / sales | 6.2×+1.0× | 5.2×+0.9× | 4.3×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TriSalus Life Sciences, Inc.'s profit margins?
- TriSalus Life Sciences, Inc. (TLSI) runs a 85.1% gross margin and a -62.4% operating margin, with a -60.9% net margin.
- Where do TriSalus Life Sciences, Inc.'s ratios come from?
- Every ratio is computed from TriSalus Life Sciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
